«Publicly, Shkreli has stated that he has philanthropic aims. (“I want to cure many diseases and save children’s lives,” he told Bloomberg Businessweek last year.) But in his decision to jack up the prices of life-saving drugs to exorbitant levels, he’s putting his own profits well ahead of any public good.»

Un article de Fusion

Martin Shkreli, boss de Turing Pharmaceuticals a acheté les droits d’un médicament (Daraprin) contre le sida. Il a aussitôt augmenté le prix de chaque pilule, de $13.50 à $750.  Protestation générale. Depuis, il engueule les opposants. Les actions de la compagnie chutent.

martin shkreli